JAYMEE:The story of Child B: Copyright 1996 by Sarah Barclay. Japanese translation rights arranged with Sarah Barclay. c/o A.P.Watt Limited,London through Tuttle-Mori Agemcy,Inc.,Tokyo. (c)Yoshiko Yamamura,Printed in japan,1998


THIS IS THE CHIRED :A father's story of his young son's battle leukemia: copyright (c)1983 by Terry Pringle. Japanese translation rights arranged with Robert Cornfield Literary Agency through Japan UNI Agency,Inc. (c)Akira Uesugi,Printed in japan,1999

社会福祉概論Ｉ（社会福祉の理論とその体系）
『新・社会福祉学習双書』編集委員会／編　全国社会福祉協議会（全社協）

NEWTIPE FILMBOOK 新世紀エヴァンゲリオン
角川書店、角川歴彦

「急性リンパ性白血病」原題 : Acute Lymphocytic Leukemia (ALL)
（Ｃ） Leukemia Society of America、米白血病協会

「小児急性骨髄性白血病」原題 : Leukemia, acute myeloid, childhood

Champlin R, Gale RP.Acute myelogenous leukemia: recent advances in therapy.Blood1987; 69: 1551-62.

Dastugue N, Payen C, Lafage-Pochitaloff M, Bernard P, Leroux D, Huguet-Rigal F, et al for the BGMT group.Prognostic significance of karyotype in de novo adult acute myeloid leukemia.Leukemia 1995; 9: 1491-8.

Preisler HD, Anderson K, Rai K, Cuttner J, Yates J, DuPre E, et al for Cancer and Acute Leukemia Group B.The frequency of long-termremission in patients with acute myelogenous leukaemia treated with conventional maintenance chemotherapy: a study of 760 patients with a minimal follow-up time of 6 years.Br J Haematol1989; 71: 189-94.

Myint H, Lucie NP.The prognostic significance of the CD34 antigen inacute myeloid leukaemia.Leuk Lymphoma1992; 7: 425-9.

Geller RB, Zahurak M, Hurwitz CA, Burke PJ, Karp JE, Piantadosi S, et al.Prognostic importance of immunophenotyping in adults with acute myelocytic leukaemia: the significance of the stem-cell glycoprotein CD34 (My10). Br J Haematol1990; 76: 340-7.

Campos L, Guyotat D, Archimbaud E, Calmard-Oriol P, Tsuruo T, Troncy J, et al.Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis.Blood1992; 79: 473-6.

Campos L, Rouault JP, Sabido O, Oriol P, Roubi N, Vasselon C, et al.High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy.Blood1993; 81: 3091-6.

Holmes R, Keating MJ, Cork A, Broach Y, Trujillo J, Dalton Jr WT, et al.A unique pattern of central nervous system leukemia in acute myelomonocytic leukemia associated with inv(16)(p13q22).Blood1985; 65: 1071-8.

Dutcher JP, Schiffer CA, Wiernik PH.Hyperleukocytosis in adult acute nonlymphocytic leukemia: impact on remission rate and duration, and survival.J Clin Oncol1987; 5: 1364-72.

Cassileth PA, Harrington DP, Appelbaum FR, Lazarus HM, Rowe JM, Paietta E, et al.Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission.N Engl J Med 1998; 339: 1649-56.

Burnett AK, Goldstone AH, Stevens RMF, Hann IM, Rees JKH, Gray RG, et al for the UK Medical Research Council Adult and Children's Leukemia Working Parties.Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML10 trial.Lancet 1998; 351:700-8.

Estey E, Thall P, Beran M, Kantarjian H, Pierce S, Keating M.Effect of diagnosis (refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, or acute myeloid leukemia [AML]) on outcome of AML-type chemotherapy.Blood 1997; 90: 2969-77.

Sanders J, Glader B, Cairo M, et al.: Guidelines for the pediatric cancer center and role of such centers in diagnosis and treatment. American Academy of Pediatrics Section Statement Section on Hematology/Oncology. Pediatrics 99(1): 139-141, 1997

Hurwitz CA, Mounce KG, Grier HE: Treatment of patients with acute myelogenous leukemia: review of clinical trials of the past decade. Journal of Pediatric Hematology/Oncology 17(3): 185-197, 1995.

Ebb DH, Weinstein HJ: Diagnosis and treatment of childhood acute myelogenous leukemia. Pediatric Clinics of North America 44(4):847-862, 1997.

Kalwinsky DK, Raimondi SC, Schell MJ, et al.: Prognostic importance of cytogenetic subgroups in de novo pediatric acute nonlymphocytic leukemia. Journal of Clinical Oncology 8(1): 75-83, 1990.

Grier HE, Gelber RD, Camitta BM, et al.: Prognostic factors in childhood acute myelogenous leukemia. Journal of Clinical Oncology 5(7): 1026-1032, 1987.

Creutzig U, Ritter J, Schellong G: Identification of two risk groups in childhood acute myelogenous leukemia after therapy intensification in study AML-BFM-83 as compared with study AML-BFM-78. Blood 75(10): 1932-1940, 1990.

Grimwade D, Walker H, Oliver F, et al.: The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. Blood 92(7): 2322-2333, 1998.

Pui CH, Relling MV, Rivera GK, et al.: Epipodophyllotoxin-related acute myeloid leukemia: a study of 35 cases. Leukemia 9(12): 1990-1996, 1995.

Zipursky A, Poon A, Doyle J: Leukemia in Down syndrome: a review. Pediatric Hematology and Oncology 9(2): 139-149, 1992.

Homans AC, Verissimo AM, Vlacha V: Transient abnormal myelopoiesis of infancy associated with trisomy 21. American Journal of Pediatric Hematology/Oncology 15(4): 392-399, 1993.

Ravindranath Y, Abella E, Krischer JP, et al.: Acute myeloid leukemia (AML) in Down's syndrome is highly responsive to chemotherapy: experience on Pediatric Oncology Group AML study 8498. Blood 80(9): 2210-2214, 1992.

小坂国男：希望骨髄移植絵物語(C)1994，発行・花伝社，販売・共栄書

大谷貴子：霧の中の生命 白血病を骨髄移植で治し、今日を生きる (C)1991 Takako Otani Printed in Japan，発行・リヨン社，発売・二見書房

十字猛夫：骨髄バンク 「一人のために」から「みんなのために」へ，(C)1994 中公新書１２１９

財団法人 日本学術協力財団：インフォームド・コンセント 〜医療現場における病名告知の是非〜 −日本学術会議主催公開講演会における記録− 日本学術会議公開公演会記録，日学双書

佐治博夫,十字猛夫,高橋孝喜：骨髄バンク入門 -Give Marrow Create New Life-，(C)1990 H.SAJI,T.JUJI,K.TAKAHASHI，あいわ出版

別冊・医学の歩み　末梢血幹細胞移植

MD アンダーソン「Living with Leukemia」

Leukemia Research Found Booklet

Cancer Net, Research report: Leukemia"

がんの子どもを守る会の小冊子 財団法人 骨髄移植推進財団（日本骨髄バンク）

骨髄バンク登録のしおり『チャンス』財団法人 骨髄移植推進財団（日本骨髄バンク）

神奈川歯科大学 臨床内科 ＤＯＣ２２ http://www.kdcnet.ac.jp/rinsyo/naika/doc22.htm

Bennett JM, Catovsky D, Daniel MT, et al.: Proposals for the classification of acute leukemias. British Journal of Haematology 33(4): 451-458, 1976.

Bennett JM, Catovsky D, Daniel MT, et al.: Proposed revised criteria for the classification of acute myeloid leukemia: a report of the French-American-British Cooperative Group. Annals of Internal Medicine 103(4): 620-625, 1985.

Bennett JM, Catovsky D, Daniel MT, et al.: Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7): a report of the French-American-British Cooperative Group. Annals of Internal Medicine 103(3): 460-462, 1985.

Bennett JM, Catovsky D, Daniel MT, et al.: A variant form of hypergranular promyelocytic leukaemia (M3). British Journal of Haematology 44(1): 169-170, 1980.

Bennett JM, Catovsky D, Daniel MT, et al.: Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO). British Journal of Haematology 78(3): 325-329, 1991.

Cheson BD, Cassileth PA, Head DR, Schiffer CA, Bennett JM, Bloomfield CD, et al.Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia.J Clin Oncol1990; 8: 813-9.

Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, et al.Proposed revised criteria for the classification of acute myeloid leukemia: a report of the French-American-British Cooperative Group.Ann Intern Med1985; 103: 620-5.

Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, et al.Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7): a report of the French-American-British Cooperative Group.Ann Intern Med1985; 103: 460-2.

Golomb HM, Rowley JD, Vardiman JW, Testa JR, Butler A."Microgranular" acute promyelocytic leukemia: a distinct clinical, ultrastructural, and cytogenetic entity.Blood1980; 55: 253-9.

Holmes R, Keating MJ, Cork A, Broach Y, Trujillo J, Dalton Jr WT, et al.A unique pattern of central nervous system leukemia in acute myelomonocytic leukemia associated with inv(16)(p13q22).Blood1985; 65: 1071-8.

Larson RA, Williams SF, Le Beau MM, Bitter MA, Vardiman JW, Rowley JD.Acute myelomonocytic leukemia with abnormal eosinophils and inv(16) or t(16;16) has a favorable prognosis.Blood 1986; 68: 1242-9.

Lee EJ, Pollak A, Leavitt RD, Testa JR, Schiffer CA.Minimally differentiated acute nonlymphocytic leukemia: a distinct entity.Blood1987; 70: 1400-6.

Yokose N, Ogata K, Ito T, Miyake K, An E, Inokuchi K, et al.Chemotherapy for minimallydifferentiated acute myeloid leukemia (AML-M0): a report on five cases and review of the literature. Ann Hematol1993; 66: 67-70.

Stasi R, Del Poeta G, Venditti A, Masi M, Stipa E, Dentamaro T, et al.Analysis of treatment failure in patients with minimally differentiated acute myeloid leukemia (AML-M0).Blood 1994; 83: 1619-25.

Imrie KR, Kovacs MJ, Selby D, Lipton J, Patterson BJ, Pantalony D, et al.Isolated chloroma: the effect of early antileukemic therapy.Ann Intern Med1995; 123:351-3.

Byrd JC, Weiss RB, Arthur DC, Lawrence D, Baer MR, Davey F, et al.Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461.J Clin Oncol1997; 15: 466-75.

Kuerbitz SJ, Civin CI, Krischer JP, et al.: Expression of myeloid-associated and lymphoid-associated cell-surface antigens in acute myeloid leukemia of childhood: a Pediatric Oncology Group study. Journal of Clinical Oncology 10(9): 1419-1429, 1992.

Smith FO, Lampkin BC, Versteeg C, et al.: Expression of lymphoid-associated cell surface antigens by childhood acute myeloid leukemia cells lacks prognostic significance. Blood 79(9): 2415-2422, 1992.

Dinndorf PA, Andrews RG, Benjamin D, et al.: Expression of normal myeloid-associated antigens by acute leukemia cells. Blood 67(4): 1048-1053, 1986.

Creutzig U, Ritter J, Schellong G: Identification of two risk groups in childhood acute myelogenous leukemia after therapy intensification in study AML-BFM-83 as compared with study AML-BFM-78. Blood 75(10): 1932-1940, 1990.

Grimwade D, Walker H, Oliver F, et al.: The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. Blood 92(7): 2322-2333, 1998.

Rubnitz JE, Look AT: Molecular genetics of childhood leukemias. Journal of Pediatric Hematology/Oncology 20(1): 1-11, 1998.

(c) Leukemia Society of America:Emotional Aspects of Childhood Leukemia A Handbook for Parents.

(c) Leukemia Society of America:Bone marrow transplantation questions and answers.

(c) Leukemia Society of America:Understanding Chemotherapy, Answers to Your Questions.

厚生省医薬品等安全性関連情報

Nishiyama H, Mokuno J, Inoue T.Relative frequency and mortality rate of various types of leukemia in Japan.Gann1969, 60: 71-81.

Weiss NS.Geographical variation in the incidence of the leukemias and lymphomas.Natl Cancer Inst Monogr 1979, 53: 139-42.

Akazaki K, Wakasa H. Frequency of lymphoreticular tumors and leukemias in Japan.J Natl Cancer Inst 1974, 52: 339-43.

Hernandez JA, Land KJ, McKenna RW.Leukemias, myeloma, and other lymphoreticular neoplasms.Cancer 1995; 75: 381-94.

がんの統計編集委員会（編）.がんの統計'97. 東京： 財団法人がん研究振興財団、1997.

DeVore R, Whitlock J, Hainsworth JD, Johnson DH.Therapy-related acute nonlymphocytic leukemia with monocytic features and rearrangement of chromosome 11q.Ann Intern Med 1989; 110: 740-2.

Detourmignies L, Castaigne S, Stoppa AM, Harousseau JL, Sadoun A, Janvier M, et al.Therapy-related acute promyelocytic leukemia: a report on 16 cases.J Clin Oncol 1992; 10: 1430-5.

Curtis RE, Boice Jr JD, Stovall M, Bernstein L, Greenberg RS, Flannery JT, et al. Risk of leukemia after chemotherapy and radiation treatment for breast cancer.N Engl J Med 1992; 326: 1745-51.

Ichimaru M, Tomonaga M, Amenomori T, Matsuo T. Atomic bomb and leukemia.J Radiat Res 1991; 32 (Suppl 2): 14-9.

Austin H, Delzell E, Cole P.Benzene and leukemia: a review of the literature and a risk assessment.Am J Epidemiol 1988; 127: 419-39.

Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, et al.Proposed revised criteria for the classification of acute myeloid leukemia: a report of the French-American-British Cooperative Group.Ann Intern Med 1985; 103: 620-5.

その他、インターネット上で公開されている手記、データ等